Effect of vaginal consumption of vitamin C supplementation in the treatment bacterial vaginitis
Phase 3
Recruiting
- Conditions
- Bacterial Vaginitis.Other bacterial agents as the cause of diseases classified elsewhere
- Registration Number
- IRCT20160905029710N2
- Lead Sponsor
- Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
Women with bacterial vaginitis base on clinical symptoms and laboratory findings
Exclusion Criteria
Patients with immunodeficiency or HIV positive
Women with genital and urinary tract infections
Menstruation at the time of attendance
Pregnant
Vitamin C sesitivity
Women who do not allow pelvic examination
Taking any vaginal drugs, antibiotics, and immune-suppressing drugs and exogenous hormones, including oral contraceptives, during the 2 weeks prior to the study.
Having intercourse or using vaginal douche within the last 24 hours
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bacterial Vaginitis. Timepoint: Clinical signs and bacterial composition of direct smear will be assessed at baseline (before intervention) and 7 days after administration of Vitamin C. Method of measurement: Questionnaire containing demographic information and clinical symptoms.;Improve vaginal bacterial composition. Timepoint: Bacterial composition of direct smear at baseline (before intervention) and 7 days after intervention. Method of measurement: Direct smear assessment before treatment.
- Secondary Outcome Measures
Name Time Method